Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 1 (2016) PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION Abstract  similar documents
M. Yu. Frolov, V. A. Rogov
"... radio iodine refractory differentiated thyroid cancer in the Russian Federation. Methods. Cost ..."
 
Vol 10, No 1 (2017) EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS Abstract  similar documents
M. Yu. Frolov, V. A. Rogov
"... aspects) drug for the treatment of widespread progressing differentiated thyroid cancer (DTC) refractory ..."
 
Vol 9, No 1 (2016) COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA Abstract  similar documents
G. R. Khachatryan, D. V. Fedyaev, M. V. Avxentyeva, V. S. Dombrovskiy
"... with relapsed or refractory CD30-positive Hodgkin’s lymphoma (HL). Materials and methods. This study ..."
 
Vol 8, No 1 (2015) BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD Abstract  similar documents
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
"... We have performed the first-ever Budget Impact Analysis (BIA) in a Russian context of bendamustine ..."
 
Vol 10, No 4 (2017) SOURCES OF BIAS IN SELF-ASSESSED HEALTH Abstract  similar documents
C. J. Gerry, V. M. Baydin
"... and quality of life of the population. However, SAH is a subjective indicator and subject to bias stemming ..."
 
Vol 9, No 2 (2016) METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY Abstract  similar documents
N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov
"... Targeted drugs are recommended for treatment of metastatic colorectal cancer. Second and further ..."
 
Vol 10, No 2 (2017) ФАРМАКОЭКОНОМИЧЕСКАЯ ОЦЕНКА ПРИМЕНЕНИЯ ПОМАЛИДОМИДА (ИМНОВИД) ДЛЯ ЛЕЧЕНИЯ БОЛЬНЫХ С РЕЦИДИВИРУЮЩЕЙ И РЕФРАКТЕРНОЙ МНОЖЕСТВЕННОЙ МИЕЛОМОЙ Abstract  similar documents
,
"... рефрактерной множественной миеломой, которые получали предшествующую терапию первой и второй линии (бортезомиб ..."
 
Vol 9, No 2 (2016) BUDGET IMPACT ANALYSIS OF PERAMPANEL FOR ADJUNCTIVE TREATMENT IN EPILEPSY PATIENTS 12 YEARS OF AGE AND OLDER FOR PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION AND PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN THE RUSSIAN FEDERATION Abstract  similar documents
V. R. Mkrtchyan, A. M. Sergeev, K. I. Pochigaeva, I. A. Shpak
"... are treated for refractory POS & PGTCS each year. The market share of perampanel in the perampanel adoption ..."
 
Vol 6, No 3 (2013) PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER Abstract  similar documents
R. I. Yagudina, I. Yu. Zinchuk
"... it was determined that for 10-years horizon cost rate for the treatment of one patient with breast cancer will be 1 ..."
 
Vol 7, No 3 (2014) PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA Abstract  similar documents
A. V. Pavlysh, A. S. Kolbin, A. R. Kasimova
"... of hospitalization (case reports) of 214 colorectal cancer patients treated with oxaliplatin at the St. Petersburg ..."
 
Vol 9, No 3 (2016) DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY Abstract  similar documents
M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov
"... cancer in various regions of the Russian Federation in the framework of state programs of drug provision ..."
 
Vol 11, No 2 (2018) Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer Abstract  similar documents
G. V. Afonin, Yu. A. Ragulin, M. V. Avxentyeva, I. A. Gulidov, S. A. Ivanov, A. D. Kaprin
"... Breast cancer remains the most common malignant neoplasm in women. According to the current ..."
 
Vol 12, No 1 (2019) Efficacy of photodynamic therapy in treatment of adult patients with skin cancer Abstract  similar documents
O. V. Kirsanova
"... Photodynamic therapy (PDT) is a relatively new non-surgical treatment for cancer and precancerous ..."
 
Vol 5, No 3 (2012) PHARMACOECONOMIC EVALUATION OF THE MEDICINAL PRODUCTS ERLOTINIB, DOCETAXEL, PEMETREXED AND GEFITINIB IN THE SECOND-LINE TREATMENT OF LOCALLY-ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER Abstract  similar documents
A. U. Kulikov
"... Abstract: lung cancer takes the second place in the general structure of incidence of malignant ..."
 
Vol 8, No 2 (2015) CLINICAL AND ECONOMIC ANALYSIS OF THE USE OF DIFFERENT TYPES OF SYSTEMS OF VENOUS ACCESS IN THE TREATMENT OF CHILDREN WITH CANCER Abstract  similar documents
Maksim Yur'evich Rykov, Vladimir Georgievich Polyakov
"... of venous access in the treatment of children with cancer. Objective: to conduct clinical and economic ..."
 
Vol 10, No 3 (2017) Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients Abstract  similar documents
N. K. Mazina, P. V. Mazin
"... Recently, an increase in the incidence of severe forms of prostate cancer, in particular ..."
 
Vol 9, No 1 (2016) COMPARATIVE CLINICAL AND ECONOMIC ANALYSIS OF THE INTENSIFICATION THERAPY IN PATIENTS WITH UNCONTROLLED DIABETES TYPE 2 USING BASAL INSULIN OR DAPAGLIFLOZIN Abstract  similar documents
V. I. Petrov, S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova, V. Yu. Khripaeva
"... according to standard pharmacoeconomic methods: cost-utility analysis (CUA), budget impact analysis (BIA ..."
 
Vol 11, No 4 (2018) “Near miss” in obstetrics: classification, evaluation, and significance for healthcare technology assessment Abstract  similar documents
I. K. Мamontova, T. V. Shevlyakovа, E. I. Petrova
"... дифференцированный подход к материнским критическим состояниям позволяет понять не только причину, но и разработать ..."
 
Vol 11, No 1 (2018) Options to optimize the access to biosimilars: analysis and solutions Abstract  similar documents
O. V. Kirsanova, V. V. Omelyanovsky
"... , including the growing use of costly medicines for cancer and rare (orphan) diseases. The  introduction ..."
 
Vol 5, No 1 (2012) PHA RMA COE CONOMI CAL EVALUATION OF MULTIPLE MYELOMA TREATMENT WITH REVLIMID (LENALIDOMIDE ) IN THE RUSSIAN FEDE RATION Abstract  similar documents
R. Yagudina, A. Kulikov, B. Misikova
"... ; 102:1115-23. 2. Boyle p, Ferlay J.Cancer incidence and mortality in europe, 2004. ann oncol. 2005 ..."
 
Vol 7, No 3 (2014) THE ANALYSIS OF METHODOLOGIC CHARACTERISTICS OF RESEARCHES ON SOCIAL AND ECONOMIC BURDEN OF DISEASES IN RUSSIA IN THE FRAMES OF DEVELOPMENT OF STANDARD COST OF ILLNESS METHODOLOGY FOR THE HEALTH TECHNOLOGY ASSESSMENT Abstract  similar documents
V. I. Ignatyeva, M. V. Avxentyeva
"... methodology on evaluation of the social and economic burden related to cancers to be used further ..."
 
Vol 7, No 2 (2014) PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD Abstract  similar documents
A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin
"... ?page_id=338. 19. http://www.pokrov.spb.ru/stoimostq-uslug.html. 20. Leoni L. et al. Clin. Cancer. Res ..."
 
Vol 6, No 1 (2013) VII CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION» Abstract  similar documents
"... pharmacoeconomic evaluation of drug supply for patients with metastatic hormone-refractory prostate cancer Когон ..."
 
Vol 9, No 4 (2016) COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY Abstract  similar documents
V. S. Dombrovskiy, G. R. Khachatryan
"... (Cancer Council Australia) по веде- нию меланомы. В этом документе не рекомендуется скрининг на- селения ..."
 
Vol 6, No 4 (2013) Pharmacoeconomical assessment of сerebrolysin in the treatment of the acute disturbances of cerebral circulation Abstract  similar documents
A. Yu. Kulikov, L. A. Komarov
"... 857 055 Без церебролизина 104 560 (55,7%) 236 678 24 747 083 048 ВСЕГО 43 237 940 103 BIA1 1 169 535 ..."
 
Vol 10, No 1 (2017) CLINICAL AND ECONOMIC EVALUATION OF ERIBULIN EFFECTIVENESS IN SOFT TISSUE SARCOMA: RESULTS OF META-ANALYSIS Abstract  similar documents
P. V. Мazin, I. V. Sheshunov, N. K. Mazina, E. M. Markova
"... cancer. 2014; 50: 679-689. 3. Феденко А. А. Стратегия лекарственного лечения сарком мягких тканей ..."
 
Vol 9, No 1 (2016) PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT Abstract  similar documents
N. K. Mazina, P. V. Mazin, Yu. V. Kislitsin, E. M. Markova
"... . 23. Joseph J., Schultz R., Wilfong A. Rufinamide for refractory epilepsy in a pediatric and young ..."
 
Vol 5, No 3 (2012) PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
A. U. Kulikov, I. A. Komarov
"... , включенным также в стандартную терапию, был рассчитан по формуле BIA = Cost1 – Cost2 , где Cost1 – общая ..."
 
Vol 5, No 2 (2012) PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS Abstract  similar documents
A. Yu. Kulikov, V. G. Serpikov
"... ,10,11]. Таким образом, результат анализа «влияния на бюджет» мож- но выразить формулой: BIA = Efec (1) – Efec ..."
 
Vol 6, No 4 (2013) Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis Abstract  similar documents
R. I. Yagudina, M. M. Murashko
"... бюджет» можно выразить формулой BIA = S(1) - S(2), (4) где BIA – результат анализа «влияния на бюджет ..."
 
Vol 6, No 4 (2013) Pharmacoepidemiology of stroke treatment in different hospitals Abstract  similar documents
N. V. Mikheeva, O. V. Reshetko, L. G. Ryzhenkova
"... . Направления дифференцированной терапии инфаркта мозга. Примечание. 1,3р<0,0001; 2р=0,0032; 4р=0,0007; 5р=0 ..."
 
Vol 5, No 2 (2012) MEDICO-ECONOMIC SUBSTANTIATION OF NORMATIVE STANDARD OF SUPPLYING STUDENTS OF MILITARY SCHOOLS WITH MEDICATIONS Abstract  similar documents
Yu. V. Miroshnichenko, V. S. Gaynov
"... исследовании применялся метод «влияния на бюджет» (Budget impact analisys, BIA), позволивший соотнести ..."
 
Vol 9, No 3 (2016) CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY Abstract  similar documents
E. A. Pyadushkina, M. Yu. Frolov
"... comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta ..."
 
Vol 6, No 2 (2013) PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS Abstract  similar documents
A. Yu. Kulikov, V. G. Serpik
"... технологий [3,10,11]. Таким образом, результат анализа «влияния на бюджет» мож- но выразить формулой BIA ..."
 
Vol 7, No 1 (2014) ROLE OF RANDOMIZED TRIALS IN PHARMACOEPIDEMIOLOGY Abstract  similar documents
T. L. Galankin, A. S. Kolbin
"... breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl ..."
 
Vol 5, No 1 (2012) UN MILLENNIUM DEVELOPMENT GOALS INDICATORS ON PROBLEMS OF ACCESS TO ESSENTIAL MEDICINES AND ENHANCEMENT OF LOCAL PHARMACEUTICAL PRODUCER IN DEVELOPING COUNTRIES Abstract  similar documents
A. Y. Kulikov, A. G. Voskanyan
"... . В странах со сред- ним уровнем дохода должна быть дифференцированная цена. Несогласованность по ..."
 
Vol 8, No 2 (2015) SYSTEMATIC LITERATURE REVIEW ON CLINICAL EFFICACY AND SAFETY OF ALOGLIPTIN IN COMPARISON WITH VILDAGLIPTIN, LINAGLIPTIN, SAXAGLIPTIN AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS Abstract  similar documents
Georgii Rubenovich Khachatryan, Vladislav Sergeevich Dombrovskii
"... заболевание сердечно-сосудистой системы (сердечная недостаточ- ность 4-й степени тяжести, рефрактерная ..."
 
Vol 7, No 1 (2014) CLINICAL AND ECONOMIC ANALYSIS IN ASSESSMENT OF HEALTH CARE TECHNOLOGIES IN HEALTH CARE INSTITUTIONS Abstract  similar documents
I. B. Gaykovaya, A. T. Burbello, A. I. Ermakov, A. S. Fedorenko, T. V. Vavilova, M. V. Komok
"... -воспалительными заболеваниями. Применение дифференцированного подхода с обязательным соблюдением показаний к ..."
 
Vol 9, No 1 (2016) PHARMACOECONOMIC SUBSTANTIATION OF APPLICATION OF GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN OUT-PATIENT CONDITIONS Abstract  similar documents
O. Yu. Korennova, L. V. Shukil', S. N. Mal'tsev, I. A. Klinyshkov, N. M. Leganova, E. A. Turusheva, T. V. Kropotina
"... treatments in refractory rheumatoid arthritis. J Clin Pharm Ther. 2011; on line. 25. Garrett S ..."
 
Vol 6, No 1 (2013) THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION Abstract  similar documents
A. Yu. Kulikov, Yu. L. Akimova
"... papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain. European Journal of Public Health. 18 (6 ..."
 
Vol 9, No 1 (2016) PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS Abstract  similar documents
N. Z. Musina, V. V. Tarasov
"... .K. Modelling cost effecriveness of Helicobacter screening to prevent gastric cancer: mandate for clinical ..."
 
Vol 8, No 4 (2015) PLANNING OF EXTENT AND FINANCIAL EXPENSES FOR DELIVERY OF HEALTH CARE IN HOSPITALS AT THE FEDERAL AND REGIONAL LEVELS Abstract  similar documents
M. V. Sura
"... дифференцированные нормативы объема медицинской помощи на одного жителя и нормативы объ- ема медицинской помощи на ..."
 
Vol 7, No 1 (2014) PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY Abstract  similar documents
D. V. Blinov
"... состояния астроглиальных клеток. GFAP содержится в глиальных филамен- тах дифференцированных астроцитов ЦНС ..."
 
Vol 7, No 2 (2014) MANAGEMENT OF MAGNESIUM DEFICIENCY IN PREGNANT WOMEN: PHARMACOEPIDEMIOLOGIC STUDY Abstract  similar documents
D. V. Blinov, U. V. Zimovina, E. M. Dzhobava
"... фермент дифференцированных нейронов, катализирующий пре- вращение 2-фосфоглицерата в фосфоенолпируват ..."
 
Vol 7, No 4 (2014) ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva
"... ,05%. Применение дифференцированных предельных торговых надбавок в амбулаторном сегменте также Д ан на я ин ..."
 
Vol 8, No 1 (2015) SOCIAL AND ECONOMIC BURDEN OF FIVE NATURAL FOCAL INFECTIONS IN THE RUSSIAN FEDERATION Abstract  similar documents
A. E. Platonov, N. A. Avksentyev, M. V. Avksentyeva, E. V. Derkach, O. V. Platonova, A. V. Titkov, N. M. Kolyasnikova
"... дифференцировано, с учетом различия раз- меров социально-экономического бремени заболеваний по регио- нам и ..."
 
Vol 5, No 1 (2012) VI CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION» Abstract  similar documents
"... исследовании применялся метод «влияния на бюджет» (Budget impact analisys, BIa), позволивший соотнести ..."
 
Vol 6, No 4 (2013) Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital Abstract  similar documents
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
"... treatment of cancer patients with deep venous thrombosis. Support Care Cancer. 2004; 12 (7): 531-6. 20 ..."
 
Vol 8, No 1 (2015) PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION Abstract  similar documents
M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach
 
1 - 50 of 53 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)